101 YuanH.LiX.ZhangX.KangR.TangD
We could see companies like Insperity (NSP) take a serious hit on the popularity of GLP-1 drugs
Naturally increases GLP-1 (glucagon-like peptide-1) hormone levels to reduce appetite, suppress cravings, and balance blood sugar levels
Semaglutide Regulatory Status in Canada Health Canada Approval Status (Ozempic, Wegovy, Rybelsus, Generic) Semaglutide is the active ingredient in three Novo Nordisk products authorized for sale in Canada: Ozempic (authorized 2018 for type 2 diabetes, with an expanded indication in 2024 to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes), Rybelsus (oral semaglutide tablets authorized for type 2 diabetes), and Wegovy (authorized 2021 for chronic weight management, with an expanded indication in 2024 to reduce the risk of non-fatal myocardial infarction, and a Notice of Compliance with Conditions issued in December 2025 for non-cirrhotic metabolic dysfunction-associated steatohepatitis with moderate to advanced liver fibrosis)
Chamma L, Chamma N, Mattar L, Slaybe M, Haidar S, Rizk R
